loader
Please Wait
Applying Filters...

Pharm-Rx Dextromethorphan Pharm-Rx Dextromethorphan

X

Looking for Prestwick3_000359? Find Controlled & Modified Release used in Prestwick3_000359 to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Gangwal Healthcare (2)

02 Nanjing Well Pharmaceutical (4)

03 Actylis (2)

04 BASF (15)

05 Corel Pharma Chem (3)

06 Finar (4)

07 Kerry (2)

08 Nomisma Healthcare (2)

09 The Dow Chemical Company (3)

filter

01 Capsule (7)

02 Cream / Lotion / Ointment (3)

03 Gel (3)

04 Granule / Pellet (1)

05 Injectable / Parenteral (1)

06 Orodispersible Tablet (1)

07 Softgels (1)

08 Solution (1)

09 Tablet (12)

10 Topical Film (2)

11 Transdermal Patch (4)

12 Transdermal patches (1)

filter

01 China (4)

02 Germany (15)

03 India (11)

04 U.S.A (7)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Ingredient(s): polyethylene glycol

Dosage Form: Capsule, Cream / Lotion / Ointment, Gel, Tablet

Category: Controlled & Modified Release, Topical

Route of Administration (Grade): Topical and Oral
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Glycerol, Unmodified, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

POLYETHYLENE GLYCOL 400 NF

URL Supplier Web Content
LM Application #LearnMore

Applications:

A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.

Ingredient(s): polyethylene glycol

Dosage Form: Cream / Lotion / Ointment, Gel

Category: Topical

Route of Administration (Grade): Topical, Parenteral
Pharmacopoeia Reference: Not Available

Technical Specifications: Low Endotoxin

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric Coatings

Ingredient(s): EthylCellulose, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

NUTRACOAT EC25D

URL Supplier Web Content
LM Application #LearnMore

Applications:

Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

Ingredient(s): Ethyl Cellulose

Dosage Form: Capsule, Granule / Pellet, Tablet

Category: Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Granulation, Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP/NF: Ethyl cellulose dispersion Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form: Capsule, Tablet, Transdermal Patch

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form: Solution, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Granulation, Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY